Angioimmunoblastic T-Cell Lymphoma Market Poised for 15.2% CAGR Growth, Reaching US$ 58.4 Bn by 2031
Market Overview The global Angioimmunoblastic T-Cell Lymphoma Market was valued at US$ 450 million in 2023 and is projected to reach US$ 850 million by 2031, registering a CAGR of 8.2% throughout the forecast period 2024–2031. The Angioimmunoblastic T-Cell Lymphoma Market is gaining momentum from rising non-Hodgkin lymphoma cases and demand for personalized treatments. Innovations in...
0 التعليقات 0 المشاركات 55 مشاهدة 0 معاينة
إعلان مُمول